Search Results 981-990 of 18951 for Neutrophil

1. Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,000/mm^3 (or ≥ 1.0 x 10^9/L);; Platelet count 75,000/mm^3 (or ≥ 75 x 10^9/L);; Hemoglobin ≥ 8 g/dL;; Serum creatinine ...

2. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3. Platelet count ≥ 100,000/mm^3. Hemoglobin > 9.0 g/dL. Total bilirubin ≤ 1.5 x upper limit of normal (ULN) ...

3. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

   Inadequate bone marrow function defined by absolute neutrophil count (ANC) < 1000 cells/mm3 in the absence of growth factor support (filgrastim within 7 ...

4. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1,500/µL. Platelets ≥ 100,000/ mm3^. Hemoglobin ≥ 10g/dL. Total serum bilirubin ≤ ULN; or total bilirubin ≤ 3.0 × ULN with ...

5. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,500/mm^3. Platelet count ≥ 100,000/mm^3. Hemoglobin ≥ 9.0 g/dL. Creatinine ≤ 1.5 x upper limit of normal (ULN). In ...

6. A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

   Absolute neutrophil count ≥ 1500mm^3;; Platelets ≥ 100,000 mm^3;; Total bilirubin ≤ 1.5 x ULN (upper limit of normal);; Aspartate Aminotransferase (AST) ...

7. Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelets (PLT) ≥ 100,000/mm^3; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN); Creatinine ...

8. Alisertib in Treating Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

   Absolute neutrophil count ≥ 1,500/mcL; Platelet count ≥ 100,000/mcL; Total bilirubin ≤ 1.5 times institutional upper limit of normal (ULN); Serum glutamic ...

9. Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma - Mayo Clinic

   Peripheral absolute neutrophil count (ANC) ≥ 750/uL; Platelet count ≥ 75,000/uL; Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 ...

10. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Absolute neutrophil count > 1500/µL; Platelet count > 100 x 103/µL; Hemoglobin > 9 g/dL, transfusion permitted; Total bilirubin < 1.5 x upper limit of normal ...